Your top candidate just cleared three rounds of interviews, accepted the offer, and gave notice at their current job. Then the pre-employment drug test comes back positive for opiates. HR pulls the file: no history of pain medication, nothing flagged anywhere earlier in the process. During the Medical Review Officer interview, the candidate mentions eating a poppy seed bagel the morning of the test. Now you’re looking at a potential false positive, a stalled start date, and a decision that has to hold up if it’s ever questioned. What do you do next?
Disclaimer: This content is provided for informational purposes only and should not be construed as legal advice. Employers should consult qualified counsel for their specific situation.
False positives can occur, particularly during the initial immunoassay stage and mishandling them can expose your organization to legal liability, damage your employer brand, and cost you qualified talent. Whether you’re the employee staring at an unexpected result or the employer trying to do the right thing, understanding how to dispute a false-positive drug test is essential knowledge.
False positives happen more often than you’d think. Common over-the-counter medications, prescription drugs, and even certain foods can trigger an inaccurate result.
Employee protections vary by program. In DOT-regulated testing, individuals are guaranteed the right to confirmatory testing, an MRO interview, and the chance to provide documentation of legitimate medication use. In non-DOT programs, these protections depend on state law, employer policy, and the testing protocol in place.
Employers carry significant responsibility. Failing to follow proper procedures when a drug test result is disputed can lead to wrongful termination claims, discrimination lawsuits, and regulatory penalties, particularly in DOT-regulated industries.
Documentation protects everyone involved. Whether you’re the person disputing the result or the HR professional managing the process, thorough records of every step safeguard rights on both sides.
A well-designed drug testing policy prevents most disputes from escalating. Clear language about confirmatory testing, MRO review, and dispute procedures sets expectations before a problem ever arises.
Drug testing is a cornerstone of many organizations’ hiring and workplace safety programs. But no screening tool is perfect, and immunoassay-based drug tests (the most common initial screening method) are designed to cast a wide net. That sensitivity is intentional; it’s designed to minimize missed positives. But it also means certain legal substances can occasionally trigger a reactive result.
Understanding why false positives occur is the first step toward handling them fairly and compliantly.
A false positive drug test occurs when an initial screening indicates the presence of a drug or its metabolites in a specimen, but the individual has not actually used the substance in question. The initial immunoassay test works by detecting chemical structures that resemble targeted drugs. The problem is that some legal, everyday substances share molecular similarities with illicit drugs, causing the test to react as though the target substance is present.
This is different from a true positive that the individual simply wants to contest. A genuine false positive means the science produced an inaccurate result, and the person is telling the truth when they say they haven’t used the drug.
|
Did You Know? Some over-the-counter medications sitting in your medicine cabinet right now, from cold remedies to pain relievers, contain active ingredients that can trigger a false positive on a standard immunoassay drug screen. |
It’s also worth noting that false positives are not the same as adulterated or substituted specimens. Those involve tampering with the sample itself. A false positive is a limitation of the initial testing methodology, which is exactly why confirmatory testing exists.
The list of substances that can cause a false positive drug test is longer than most people expect. This is largely because several widely used medications contain compounds that are structurally similar to controlled substances.
Common culprits include:
Pseudoephedrine and phenylephrine, found in many cold and sinus medications, which can trigger a presumptive false positive for amphetamines on the initial immunoassay screen. Modern confirmatory testing and MRO review are designed to distinguish these medications from actual amphetamine use.
Ibuprofen, which has been associated with false positives for marijuana (THC) and barbiturates on older immunoassay panels, though modern assays have largely reduced this cross-reactivity.
Dextromethorphan, a cough suppressant found in dozens of OTC products, which can trigger false positives for PCP or opioids.
Poppy seeds, which contain trace amounts of morphine and codeine and can cause a positive opiate result, though current federal testing cutoff levels have significantly reduced how often this actually happens in workplace testing.
Certain antihistamines and sleep aids, including diphenhydramine, which have been linked to false positives for PCP (and, less commonly, methadone) on some panels.
|
Pro Tip: Employees should always disclose any medications, supplements, or relevant dietary items to the testing administrator or Medical Review Officer before or immediately after the test. This disclosure doesn’t guarantee a negative result, but it creates a documented record that can be critical during the review process. |
A false positive isn’t a minor inconvenience. For both the individual and the organization, the fallout can be significant and lasting if the situation isn’t handled correctly.
For the person on the receiving end, a false positive drug test can be deeply unsettling. The most immediate fear is job loss. A candidate may have their offer rescinded. A current employee may face suspension, termination, or mandatory treatment referrals. These consequences land on someone who didn’t do anything wrong.
Beyond employment, the reputational risk deserves an accurate description. In DOT-regulated consortiums, specific reporting rules govern how a drug test result is shared between employers, and a properly resolved false positive generally should not follow a worker from job to job. The emotional toll is real, too: anxiety, anger, and a sense of helplessness are common reactions, especially when the individual doesn’t understand their rights or the dispute process.
For individuals on probation, the stakes are even higher. A false positive drug test in a probation context can lead to revocation hearings, incarceration, or extended supervision.
Anyone wondering how to dispute a false-positive drug test on probation should know that the same scientific principles apply: confirmatory testing through GC-MS or LC-MS/MS (highly specific laboratory methods that can distinguish between the target drug and cross-reacting substances) can differentiate a true positive from a false one. However, the legal process for challenging the result will differ from an employment context, and retaining an attorney familiar with criminal defense or probation law is strongly advisable.
Employers who act too quickly on an unconfirmed positive result, terminating or rescinding an offer without following proper procedures, open themselves up to legal exposure. This can potentially include wrongful termination claims, discrimination lawsuits under Title VII (if disparate impact on a protected class is alleged) or the Americans with Disabilities Act, and state-specific causes of action.
Beyond litigation risk, there’s the human capital cost. Losing a qualified hire or a productive employee over a result that turns out to be inaccurate wastes recruiting dollars, disrupts team productivity, and can erode trust across the workforce. If word gets out that your organization doesn’t handle disputes fairly, it can damage your employer brand in a tight labor market.
|
Pro Tip: Implement a clear, written policy for handling disputed drug test results before you ever need one. Have employment counsel review the policy before you roll it out. It should outline the confirmatory testing process, the role of the Medical Review Officer, timelines for the employee or candidate to respond, and the steps your organization will take before making any adverse employment decision. |
For individuals challenging the result and HR professionals managing the process alike, there’s a structured path forward. Methodical, well-documented steps protect rights on both sides.
If you’ve received a drug test result that you believe is inaccurate, remain composed, but act promptly. Time matters in this process.
Stay calm and don’t refuse to engage. Refusing to participate in the review process or becoming confrontational can work against you. Cooperate fully while asserting your rights.
Request to speak with the Medical Review Officer (MRO). The MRO interview is your first opportunity to explain any legitimate medical reason for the result.
Disclose all medications and supplements. Provide the MRO with a complete list of everything you’ve taken, including prescriptions, OTC medications, herbal supplements, and relevant dietary items like poppy seed products. Bring prescription bottles or pharmacy printouts if possible.
Request confirmatory testing. If the initial immunoassay was positive, confirmatory testing using GC-MS or LC-MS/MS is far more specific and can distinguish between the target drug and a cross-reacting substance. In many cases, this confirmatory test is already part of the standard protocol, but you should confirm that it has been or will be performed.
Document everything. Keep a written record of dates, times, names of people you spoke with, and the content of each conversation. Save copies of any written communications.
Employees and candidates have more protections than many realize. Under the Fair Credit Reporting Act (FCRA), when a drug test is conducted as part of a background screening through a third-party consumer reporting agency (a key distinction, as the FCRA applies specifically in this scenario), the individual must receive a copy of the report and a summary of their rights before any adverse action is taken. This gives the person an opportunity to dispute the result.
In DOT-regulated industries, the process is even more structured. The Department of Transportation’s 49 CFR Part 40 outlines specific procedures for MRO review, split-specimen testing, and the employee’s right to have the second specimen (the “B” bottle) tested at a different SAMHSA-certified laboratory.
|
Did You Know? Under DOT-regulated testing, employees have the right to request that the split specimen (B bottle) be sent to a different certified laboratory for independent confirmatory testing. Responsibility for payment varies under DOT rules and employer policy. |
Many states also have their own drug testing statutes that provide additional protections, including requirements for confirmatory testing, MRO review, and the right to explain a positive result before any employment action is taken. Because these laws vary significantly by state, you should consult with an employment attorney in your jurisdiction.
HR professionals and compliance managers play a pivotal role in ensuring that disputed drug test results are handled fairly, consistently, and in compliance with applicable law.
Verify that confirmatory testing was performed. Never take action based solely on an initial immunoassay screen. Confirm with your testing provider or MRO that GC-MS or LC-MS/MS confirmatory testing was completed and that the result was reviewed by a qualified Medical Review Officer.
Ensure the MRO interview occurred. The MRO should have contacted the donor to discuss the result and any legitimate medical explanations. If this step was skipped or incomplete, the result should not be considered final.
Review chain of custody documentation. Confirm that the specimen was collected, transported, and tested according to proper chain of custody protocols. Any break in the chain can compromise the integrity of the result.
Allow the individual to provide additional documentation. If the employee or candidate provides prescription records, a letter from their physician, or other relevant evidence, this information should be forwarded to the MRO for consideration.
Employers must tread carefully when a drug test result is disputed. Taking adverse action without following proper procedures (whether that means rescinding an offer, terminating employment, or imposing discipline) can create significant legal exposure.
If your drug testing program is administered through a third-party screening provider (which it should be, for compliance purposes), the FCRA’s adverse action requirements apply. This means providing a pre-adverse action notice with a copy of the report, waiting a reasonable period for the individual to respond, and then issuing a final adverse action notice if you proceed.
For DOT-regulated employers, the stakes are particularly high. Non-compliance with 49 CFR Part 40 can result in federal enforcement action, fines, and audit findings.
|
Pro Tip: Consult with legal counsel before making any employment decision based on a disputed drug test result. The cost of a brief legal consultation is a fraction of the cost of defending a wrongful termination or discrimination claim. |
Whether you’re building a drug testing program from scratch or refining an existing one, these steps will help you handle false positive situations with confidence and compliance.
Require confirmatory testing in every case. Never make an employment decision based solely on a presumptive positive initial immunoassay screen. Your policy should mandate GC-MS or LC-MS/MS confirmatory testing for all presumptive positive results.
Partner with a qualified Medical Review Officer. The MRO is the linchpin of a compliant drug testing process. Ensure your MRO is a licensed physician with appropriate certification and training in drug testing review.
Document your drug testing policy thoroughly. Your policy should cover specimen collection procedures, the testing panel used, confirmatory testing protocols, MRO review, the dispute process, timelines for the individual to respond, and the specific employment actions that may result from a confirmed positive.
Train your HR team on adverse action procedures. If your drug testing is conducted through a third-party screening provider, FCRA adverse action requirements apply. Make sure everyone involved in the hiring or discipline process understands the pre-adverse action notice, waiting period, and final adverse action notice requirements.
Know your DOT obligations. If your organization employs safety-sensitive workers regulated by the Department of Transportation, you must follow 49 CFR Part 40 to the letter. This includes using SAMHSA-certified laboratories, following specific MRO procedures, and honoring the employee’s right to split-specimen testing.
Create a clear dispute resolution pathway. Employees and candidates should know exactly how to raise a concern about a drug test result, who to contact, what documentation to provide, and what timeline to expect.
Consult legal counsel proactively. Don’t wait until you’re facing a dispute to involve your employment attorney. Have counsel review your drug testing policy annually, especially given the rapidly changing landscape of AccuSourceHR’s state marijuana legislation and drug testing restrictions guide.
At AccuSourceHR, we understand that drug testing is one of the most sensitive components of your background screening program. A false positive can disrupt a hire, damage a relationship, and create compliance exposure if it’s not handled correctly. That’s why our PBSA-certified, FCRA-compliant team works with qualified Medical Review Officers and SAMHSA-certified laboratories to ensure that every drug test result goes through proper confirmatory testing and review before it ever reaches your desk.
Our compliance team stays current on federal, state, and local drug testing regulations so you don’t have to track every change on your own. Whether you’re managing a DOT-regulated program or a standard pre-employment panel, our 100% US-based support team is here to help you manage disputed results, refine your policies, and keep your program compliant. Through our SourceDirect™ platform, you can track the status of every test in real time and maintain the documentation trail that protects your organization.
Resolving a false positive drug test dispute requires collaboration, not confrontation. Employees who approach the process calmly, provide documentation, and exercise their rights to confirmatory testing and MRO review will generally find that the system works in their favor when the initial result was truly inaccurate. Employers who follow established protocols, rely on qualified MROs, and treat disputed results as a compliance process rather than an adversarial one will protect both their organizations and their people.
The goal on both sides is the same: an accurate result and a fair outcome. When the testing process includes proper safeguards, most false positives are caught and corrected before any employment action is taken. Disputes escalate when shortcuts replace protocols, policies lack specificity, or decisions rest on unconfirmed initial screens.
Have you ever had to handle a false positive drug test situation, either as an HR professional or as the person disputing the result? Share your experience with our team, or reach out if you’d like to talk through your drug testing program. We’re always happy to help.